Marks Fine Chemicals Profile
Key Indicators
- Authorised Capital ₹ 0.80 M
as on 21-12-2024
- Paid Up Capital ₹ 0.79 M
as on 21-12-2024
- Company Age 41 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 5.33 M
as on 21-12-2024
- Revenue -44.60%
(FY 2016)
- Profit 16.24%
(FY 2016)
- Ebitda 16.64%
(FY 2016)
- Net Worth -183.60%
(FY 2016)
- Total Assets -22.65%
(FY 2016)
About Marks Fine Chemicals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.80 M and a paid-up capital of Rs 0.79 M.
The company has closed loans amounting to ₹5.33 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Maya Nair, Madhavan Nair, and Ramankutty Venugopal serve as directors at the Company.
- CIN/LLPIN
U24110TG1983PTC003901
- Company No.
003901
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Apr 1983
- Date of AGM
28 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Nellore, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Marks Fine Chemicals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maya Nair  | Director | 15-Sep-2006 | Current |
| Madhavan Nair | Director | 11-Apr-1983 | Current |
| Ramankutty Venugopal | Director | 30-Aug-2013 | Current |
Financial Performance of Marks Fine Chemicals.
Marks Fine Chemicals Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 44.6% decrease. The company also saw a substantial improvement in profitability, with a 16.24% increase in profit. The company's net worth observed a substantial decline by a decrease of 183.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Marks Fine Chemicals?
In 2017, Marks Fine Chemicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 09 Feb 1994 | ₹1.50 M | Satisfied |
Canara Bank Creation Date: 03 Apr 1991 | ₹0.17 M | Satisfied |
Canara Bank Creation Date: 08 Feb 1990 | ₹0.80 M | Satisfied |
How Many Employees Work at Marks Fine Chemicals?
Marks Fine Chemicals has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marks Fine Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marks Fine Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
